Nonsteroidal anti-inflammatory drugs and the risk of hospitalization for acute renal failure. 1996

S Pérez Gutthann, and L A García Rodríguez, and D S Raiford, and A Duque Oliart, and J Ris Romeu
Pharmacoepidemiology Research, Ciba-Geigy, Spain.

BACKGROUND Few studies have evaluated the association between use of nonsteroidal anti-inflammatory drugs (NSAIDs) and the risk of idiopathic acute renal failure (ARF) in the general population. METHODS Population-based case-control study among persons in the Canadian province of Saskatchewan who received at least 1 NSAID prescription between January 1, 1982, and December 31, 1986. Health department databases were used for case detection, as the sampling frame for selecting controls (n = 1997), and as the primary source of information on drug use and comorbidity. A total of 306 hospital records were reviewed. Twenty-eight patients who were hospitalized fulfilled the diagnostic criteria for ARF. RESULTS The incidence rate of hospitalization for ARF among the general population not exposed to NSAIDs was 2 per 100000 person-years. Current exposure to NSAIDs, acetylsalicylic acid and other nephrotoxic drugs, male gender, increasing age, cardiovascular comorbidity, and recent hospitalization for disorders other than renal were found to be independent risk factors for ARF. Current NSAID users had an adjusted odds ratio for ARF of 4.1 (95% confidence interval, 1.5-10.8). The risk of ARF was especially high during the first month of use (odds ratio, 8.5). For prescribed dose, we found that users of high daily doses of NSAIDs experienced an odds ratio of 9.8 for ARF. CONCLUSIONS In the general population, hospitalizations for ARF were found to be a rare condition. The 4-fold increase in risk associated with NSAID use was dose-dependent and occurred especially during the first month of therapy. Concurrent comedication with other potentially nephrotoxic agents should be prescribed with care, especially in the elderly.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006760 Hospitalization The confinement of a patient in a hospital. Hospitalizations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents
D012306 Risk The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome. Relative Risk,Relative Risks,Risk, Relative,Risks,Risks, Relative

Related Publications

S Pérez Gutthann, and L A García Rodríguez, and D S Raiford, and A Duque Oliart, and J Ris Romeu
May 1995, Seminars in nephrology,
S Pérez Gutthann, and L A García Rodríguez, and D S Raiford, and A Duque Oliart, and J Ris Romeu
August 1995, QJM : monthly journal of the Association of Physicians,
S Pérez Gutthann, and L A García Rodríguez, and D S Raiford, and A Duque Oliart, and J Ris Romeu
May 1992, Archives of internal medicine,
S Pérez Gutthann, and L A García Rodríguez, and D S Raiford, and A Duque Oliart, and J Ris Romeu
November 1996, Drugs & aging,
S Pérez Gutthann, and L A García Rodríguez, and D S Raiford, and A Duque Oliart, and J Ris Romeu
January 1987, Nephron,
S Pérez Gutthann, and L A García Rodríguez, and D S Raiford, and A Duque Oliart, and J Ris Romeu
September 1982, Mayo Clinic proceedings,
S Pérez Gutthann, and L A García Rodríguez, and D S Raiford, and A Duque Oliart, and J Ris Romeu
November 1996, Archives of internal medicine,
S Pérez Gutthann, and L A García Rodríguez, and D S Raiford, and A Duque Oliart, and J Ris Romeu
August 1991, Annals of internal medicine,
S Pérez Gutthann, and L A García Rodríguez, and D S Raiford, and A Duque Oliart, and J Ris Romeu
June 1983, Archives of internal medicine,
S Pérez Gutthann, and L A García Rodríguez, and D S Raiford, and A Duque Oliart, and J Ris Romeu
January 2003, Drugs,
Copied contents to your clipboard!